Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.74M Sell
33,172
-51,829
-61% -$2.74M 0.01% 190
2026
Q1
$4.69M Buy
+85,001
New +$4.61M 0.02% 126

Other funds holding GSK

Blackstone Inc's GSK Position: Q2 2026 in Review

Blackstone Inc reduced its GSK (GSK) stake by 61% in Q2 2026, selling an estimated $2.74M and leaving 33,172 shares worth $1.74M. The position accounts for 0.01% of the portfolio, ranked #190.

Blackstone Inc first reported a position in GSK in Q1 2026 and has held it in 2 quarters since. The position peaked at $4.69M in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Blackstone Inc held 33,172 shares of GSK worth $1.74M as of Q2 2026.
  • Blackstone Inc sold 51,829 GSK shares in Q2 2026, an estimated $2.74M.
  • GSK made up 0.01% of Blackstone Inc's portfolio in Q2 2026, its #190 holding.
  • Blackstone Inc first reported a position in GSK in Q1 2026 and has held it in 2 quarters since.
  • Blackstone Inc's GSK position peaked at $4.69M in Q1 2026.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Blackstone Inc's 13F filing for Q2 2026, filed 14 Aug 2026.